Traws Pharma (TRAW) Institutional Ownership $1.58 +0.10 (+6.76%) Closing price 07/16/2025 04:00 PM EasternExtended Trading$1.57 -0.01 (-0.38%) As of 07/16/2025 07:56 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ownership Stock AnalysisChartCompetitorsEarningsFDA EventsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for Traws Pharma (NASDAQ:TRAW)CurrentInstitutional OwnershipPercentage7.95%Number ofInstitutional Buyers(last 12 months)7TotalInstitutional Inflows(last 12 months)$3.31MNumber ofInstitutional Sellers(last 12 months)1TotalInstitutional Outflows(last 12 months)$147.39K Get TRAW Insider Trade Alerts Want to know when executives and insiders are buying or selling Traws Pharma stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data TRAW Institutional Buying and Selling by Quarter Traws Pharma Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails5/16/2025Alyeska Investment Group L.P.52,630$121K0.0%-54.9%0.987% 5/16/2025Adage Capital Partners GP L.L.C.330,000$759K0.0%N/A6.187% 5/15/2025Vestal Point Capital LP175,000$402K0.0%+133.3%3.281% 2/17/2025Vestal Point Capital LP75,000$666K0.0%N/A2.055% 2/17/2025Millennium Management LLC10,012$89K0.0%N/A0.274% 2/17/2025Alyeska Investment Group L.P.116,714$1.04M0.0%N/A3.198% 2/14/2025Boothbay Fund Management LLC28,431$252K0.0%N/A0.779% 2/13/2025Renaissance Technologies LLC10,052$89K0.0%N/A0.275% 2/12/2025Geode Capital Management LLC20,801$185K0.0%N/A0.570% (Data available from 1/1/2016 forward) TRAW Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of TRAW shares? During the previous two years, the following institutional investors and hedge funds held shares of Traws Pharma shares: Adage Capital Partners GP L.L.C. ($759K), Vestal Point Capital LP ($402K), Boothbay Fund Management LLC ($252K), Geode Capital Management LLC ($185K), Alyeska Investment Group L.P. ($121K), and Millennium Management LLC ($89K), and Renaissance Technologies LLC ($89K).Learn more on Traws Pharma's institutional investors. What percentage of Traws Pharma's stock is owned by institutional investors? 7.95% of Traws Pharma's stock is owned by institutional investors. Learn more on TRAW's institutional investor holdings. Which institutional investors have been buying Traws Pharma's stock? The following institutional investors have purchased Traws Pharma's stock in the last 24 months: Adage Capital Partners GP L.L.C. ($330K), Vestal Point Capital LP ($175K), Alyeska Investment Group L.P. ($116.71K), Boothbay Fund Management LLC ($28.43K), Geode Capital Management LLC ($20.80K), Renaissance Technologies LLC ($10.05K), and Millennium Management LLC ($10.01K). How much institutional buying is happening at Traws Pharma? Institutional investors have bought a total of 691,010 shares in the last 24 months. This purchase volume represents approximately $3.31M in transactions. Which of Traws Pharma's major shareholders have been selling company stock? The following institutional investors have sold Traws Pharma stock in the last 24 months: Alyeska Investment Group L.P. ($64.08K). How much institutional selling is happening at Traws Pharma? Institutional investors have sold a total of 64,084 shares in the last 24 months. This volume of shares sold represents approximately $147.39K in transactions. Related Companies Clene Institutional Ownership KALA BIO Institutional Ownership OnKure Therapeutics Institutional Ownership Kezar Life Sciences Institutional Ownership Estrella Immunopharma Institutional Ownership Ovid Therapeutics Institutional Ownership Synergy CHC Institutional Ownership Marinus Pharmaceuticals Institutional Ownership Allakos Institutional Ownership MiNK Therapeutics Institutional Ownership This page (NASDAQ:TRAW) was last updated on 7/17/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredTurn $1K into $50K with This DeFi GemI've never been more confident about a DeFi opportunity. This isn't about complex trading or risky bets. Th...Crypto 101 Media | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Traws Pharma, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Traws Pharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free TRAW Stock Alerts